Study on the Effectiveness of Journaling As an Add-on to Cognitive Behavioral Therapy
Launched by UNIVERSITY HOSPITAL TUEBINGEN · Mar 4, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how writing in a therapy journal might improve the effectiveness of cognitive behavioral therapy (CBT) for people dealing with various mental health challenges, such as mood disorders, trauma from childhood, eating disorders, and substance use issues. The researchers want to see if adding journaling—where patients write about their thoughts and feelings—can help them set goals and reflect on their progress between therapy sessions. To find out, they will enroll 80 participants who are currently receiving CBT and divide them into two groups: one group will continue with standard CBT, while the other group will do CBT along with journaling.
If you or someone you know is between the ages of 18 and 65 and is currently in outpatient CBT, you may be eligible to participate in this study. There are no specific exclusions, so most people in CBT can join. Those who take part can expect to engage in their usual therapy sessions while also keeping a journal to enhance their self-reflection and goal-setting. This could be a great opportunity to learn more about how journaling might support your mental health journey!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients in ambulant cognitive behavioral therapy
- Exclusion Criteria:
- • none
About University Hospital Tuebingen
University Hospital Tübingen is a leading academic medical institution in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and cutting-edge facilities to develop new therapeutic strategies and improve patient outcomes. With a strong focus on translational medicine, University Hospital Tübingen collaborates with various stakeholders, including pharmaceutical companies and research organizations, to facilitate the efficient and ethical conduct of trials across a wide range of medical disciplines. Their dedication to patient-centered research and rigorous scientific standards positions them at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tübingen, , Germany
Patients applied
Trial Officials
Ann-Christine Ehlis, Dr.
Principal Investigator
University Hospital Tübingen Department of Psychiatry and Psychotherapy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported